Cytek Biosciences, Inc. CTKB APAC — Total revenue, net
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s apac — total revenue, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s APAC — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported APAC — total revenue, net of $7.75M in Q1 2026.
- How has Cytek Biosciences, Inc.'s APAC — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s APAC — total revenue, net decreased by 12.8% year-over-year, from $8.89M to $7.75M.
- What is the long-term trend for Cytek Biosciences, Inc.'s APAC — total revenue, net?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s APAC — total revenue, net has grown at a 26.4% compound annual growth rate (CAGR), from $16.08M to $41.08M.
- What does APAC — total revenue, net mean?
- This metric represents the total net revenue generated from the Asia-Pacific geographic region, reflecting the company's market penetration and commercial success in these specific international markets. It serves as a key indicator of the company's ability to scale its global footprint and capture demand for its specialized technology within this territory.